Active Ingredient: MILTEFOSINE
Proprietary Name: IMPAVIDO
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 50MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N204684
Product Number: 001
Approval Date: Mar 19, 2014
Applicant Holder Full Name: KNIGHT THERAPEUTICS USA INC
Marketing Status:
Prescription
Patent and Exclusivity Information
